跳至主要内容
临床试验/IRCT2012121711785N1
IRCT2012121711785N1已完成2 期

The effect of coenzyme Q10 supplementation on glycemic control, inflammatory markers, lipid profile, oxidative stress and blood pressure in type 2 diabetic patients: a placebo-controlled trial

Shiraz University of Medical Sciences0 个研究点目标入组 54 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 60 years(—)
性别
All

入选标准

  • Type 2 diabetic patients, with body mass index 20-30.
  • Exclusion criteria: Patients with any chronic renal, hepatic and gastrointestinal disorders, using anticoagulants, lipid lowering medications and ß-blockers, consumption of vitamin-mineral supplements, following specific diets and smokers. In the case of decreasing or increasing the blood glucose lowering medications the patient will be excluded from the study.

排除标准

  • 未提供

研究者

相似试验